Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter.

Background: Gliomas are the most common primary tumors in central nervous system. The prognosis of the patients with glioma is poor regardless of the development of therapeutic strategies. Its aggressive behavior mainly depends on the potent ability of proliferation.